dc.contributor.author | McEvoy, Kelsey | |
dc.date.accessioned | 2013-12-24T13:32:57Z | |
dc.date.available | 2013-12-24T13:32:57Z | |
dc.date.issued | 2012-06-18 | |
dc.identifier.citation | p. 1280 | en_US |
dc.identifier.isbn | 978-967-5760-11-2 | |
dc.identifier.uri | http://dspace.unimap.edu.my/123456789/30835 | |
dc.description | The 2nd International Malaysia-Ireland Joint Symposium on Engineering, Science and Business 2012 (IMiEJS2012) jointly organized by Universiti Malaysia Perlis and Athlone Institute of Technology in collaboration with The Ministry of Higher Education (MOHE) Malaysia, Education Malaysia and Malaysia Postgraduates Student Association Ireland (MyPSI), 18th - 19th June 2012 at Putra World Trade Center (PWTC), Kuala Lumpur, Malaysia | en_US |
dc.description.abstract | Cronobacter spp. (previously Enterobacter sakazakii) are bacteria described as emerging
opportunistic food-borne pathogens. Neonates and infants are most at risk from infection and
powdered infant formula (PIF) has been implicated as the source of infection in the majority of
outbreaks. The sources of contamination, ecology and virulence characteristics of this genus are, as
yet, poorly understood. There is a need to identify traits related to its pathogenesis and persistence
in suspected food sources, especially PIF. An impressive 15% of the world’s PIF is made in Ireland
and an outbreak of Cronobacter would have serious detrimental consequences to the economy. This
study aims to develop a novel food grade antimicrobial effective in interfering with the
pathogenesis of Cronobacter spp. The development of such an agent, and its possible inclusion in
PIF is a conceptually encouraging solution to the potentially devastating effects of a Cronobacter
outbreak in Ireland. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Universiti Malaysia Perlis (UniMAP) | en_US |
dc.relation.ispartofseries | The 2nd International Malaysia-Ireland Joint Symposium on Engineering, Science and Business 2012 (IMiEJS2012); | |
dc.subject | Cronobacter spp. (Enterobacter sakazakii) | en_US |
dc.subject | Pathogenesis | en_US |
dc.subject | Novel antimicrobials | en_US |
dc.subject | Powdered infant formula (PIF) | en_US |
dc.title | Interfering with the pathogenesis pathway of Cronobacter spp using novel antimicrobials | en_US |
dc.type | Other | en_US |